ANI Pharmaceuticals, Inc. (ANIP)

81.88 +1.15 (+1.42%) USD  |  NASDAQ  |  Dec 24, 10:51
More

ANI Pharmaceuticals SG&A Expense (TTM): 304.67M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
CorMedix, Inc. 75.56M
Arcutis Biotherapeutics, Inc. 253.18M
Intellia Therapeutics, Inc. 119.17M
Castle Biosciences, Inc. 222.56M
Amicus Therapeutics, Inc. 353.07M